|
Summary of the investigation: with the available information, bsc cannot confirm the clinical observations due to lack of product return.Device history record review: a review of the device history record (dhr) was performed.The review of the dhr identified that there were no process related non-conformances, scrap, or rework performed during the production that could explain the event.The reviews ensure each device meets specification prior to release for use.There is no indication the device manufacturing process contributed to the reported complaint.Device technical analysis: this device has not been returned; therefore, technical analysis cannot be conducted.Without a returned device it is not possible to definitively confirm how the device may have contributed to the complaint incident.As no further information concerning this report is expected, our investigation is complete.This investigation will be updated should further information be provided.Labeling review: review of labeling determined the complaint situation was listed in the manual.There was no indication in the complaint that the product was not used in accordance to labeling.The manual was unlikely to be the cause of the reported complaint; translation, wording, or graphics does not required further review.Investigation conclusion: reported adverse event known and documented in the labeling (including both short or long term known complications or adverse reactions).
|
|
It was reported that this implantable cardioverter defibrillator (icd) exhibited high out of range shock impedance measurement of greater than 150 ohms on the right ventricular (rv) lead channel.A lead revision procedure was scheduled.Additional information has been requested to the hospital regarding the event resolution, but no information was received.At this time, the device remains in service.There was no adverse patient effects were reported.
|